Compare Different
Treatment Options

Comparing Different Treatment Options

Men need a simple way to compare prostate cancer treatment methods and their outcomes. This study group from the Prostate Cancer Free Foundation is an assembly of experts from each specialty: Surgery, External beam radiation therapy (EBRT), Internal radiation/brachy, HIFU, Proton therapy.

The purpose is to have a complete review of current and up to date literature. Currently PSA is the best measurement tool today, (even though it cannot answer absolutely) therefore can only indicate treatment is successful if PSA shows that there is no prostate cancer progression.

In order to compare prostate cancer treatment options, you need to begin by gathering information about your own prostate cancer diagnosis. Your doctor will provide three elements that describe your prostate cancer; your PSA, Stage and Gleason Score. These three elements help you determine your risk group. Find and select your Risk Group in the table below the video. This will take you to the comparing prostate cancer treatments page, where you can select different prostate cancer treatments on an interactive chart and graphically see their effectiveness over time.

Treatment outcomes show how many patients remain prostate cancer free, and for how many years following treatment. These comparisons are done by patient Risk Group. Patients with prostate cancer that has been detected early, fall into the low risk group. Those with more advanced cancer will fall into intermediate or high risk groups of prostate cancer.

Learn Your Prostate Cancer Risk Group

Low Risk
PSA less than 10, and
Gleason Score less than 7, and
Clinical Stage is T1c to T2a
Intermediate Risk
PSA greater than 10 less than 20, or
Gleason Score is 7, or
Clinical Stage is T2b
High Risk
PSA greater than 20, or
Gleason Score is 8 to 10, or
Clinical Stage is T2c to T3c
Scroll to Top